R
Regeneron Pharmaceuticals, Inc. stock price
REGN · NMS · stock
$927.89▲ 109.12 (13.33%)
Open
$869.43
Prev close
$818.77
Day high
$935.35
Day low
$839.08
52-wk high
$935.35
52-wk low
$591.52
P/E (TTM)
18.20×
Net margin
32.40%
🔔 Get a free alert when Regeneron Pharmaceuticals, Inc. moves
Set a price alert, save REGN to your watchlist, and unlock the full AI deep dive. Free account — 10 seconds with Google, no password.
Create free account →
Regeneron Pharmaceuticals, Inc. (REGN) is a US-listed company (NYSE / Nasdaq). Traddx shows its live price, interactive candlestick charts, quarterly financials straight from SEC filings, a Groww-style health scorecard, and support/resistance — plus Athena, our US research analyst, for a plain-English take.
Quarterly financials
| Quarter | Revenue $M | YoY | Net profit $M | EPS $ |
|---|---|---|---|---|
| Q3 2026 | 5,115.80 | +36.30% | 1,948.70 | 18.45 |
| Q2 2026 | 4,290.70 | +16.70% | 1,296.90 | 12.23 |
| Q1 2026 | 3,605.40 | +19.00% | 727.20 | 6.75 |
| Q3 2025 | 3,754.30 | +0.90% | 1,460.00 | 13.62 |
| Q2 2025 | 3,675.60 | +3.60% | 1,391.60 | 12.81 |
| Q1 2025 | 3,028.70 | -3.70% | 808.70 | 7.27 |
| Q3 2024 | 3,720.70 | +10.60% | 1,340.60 | 11.54 |
| Q2 2024 | 3,547.10 | +12.30% | 1,432.30 | 12.41 |
Figures in US$ millions, latest first (source: SEC filings).